Bradsaúde faces high medical expenses and high costs in the third quarter
Statements (8)
- Bullish
Bradsaúde (SAUD3) reported higher-than-expected net income despite rising claims.
- Bullish
Bradsaúde (SAUD3) passed the third-quarter sinistrality test, with the market celebrating the move.
- Bullish
Bradsaúde reported a third-quarter operating loss that was more favorable than consensus estimates
- Neutral
BradSaúde (SAUD3) posted a strong balance sheet for the third quarter, with a loss ratio of 84.5%.
- Bullish
Bradsaúde reported a 14.4% increase in net profit in the period between July and September
- Neutral
BradSaúde reported a total revenue of R$ 14.275 billion in the third quarter.
- Bearish
Bradsaúde (SAUD3) faces increased pressure on margins due to high medical expenses in the new reporting season.
- Bearish
Bradsaúde (SAUD3) faces higher costs and pressured profits in the third quarter of 2026.